• Tue news: Where do Harris and Trump stand on health policy? Medtronic renal denervation coverage. Canada less likely to have drug shortages? Wall Street wants CVS execution plan. Nektar manufacturing facility sale. See more on our front page

fired

  1. Massive Layoffs

    Lots of us affected, the vast majority being Scarlet. The division is all but gone. About 33 phlebotomists remain nationwide - originally we had about 250 nationwide. I bet we'd be in a stronger position if we didn't have a 10 million dollar lawsuit to pay.
  2. 2 small biopharma CEOs that should be sacked

    Check this out from Seeking Alpha: https://www.google.com/amp/s/seekingalpha.com/amp/article/4133495-2-small-biopharma-ceos-sacked "I refer, of course, to Egalet (EGLT). It is hard to imagine a company that has done a better job of destroying shareholder value here in 2017 as the chart below...